Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Feb 13,2026
Price(EOD): ₹ 67.23
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 190.93 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on Feb 15,2021 (price: ₹ 28.05)

₹ 1 L

₹ 2.40 L

1W : -3.8% 1M : 5.2% 1Y : 42.6%
AD     Remove this Ad
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS -3.8% 5.2% 42.6%
SUN PHARMACEUTICAL INDUSTRIES -0.4% -0.1% -2%
DIVIS LABORATORIES 0.9% -3% 0.8%
CIPLA -0.9% -7.2% -9.7%
TORRENT PHARMACEUTICALS 2% 1.7% 25.2%
DR REDDYS LABORATORIES -0.6% 6.8% 2.7%
MANKIND PHARMA -1.1% -8.2% -17.5%
ZYDUS LIFESCIENCES -2% 2.4% -7.4%
LUPIN 0% 0.2% 0.5%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Dec2025, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Feb 13,2026 ]

Ratio Standalone
P/E
P/B
P/S
55.48
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3.44 Cr
[Latest Qtr - Dec2025 - Standalone Results ]

1.4
P/B Calculated based on Book Value of Rs 135.97 Cr
[Latest Year - Mar2025 - Standalone Results ]

0.49
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2025 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 74% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
8410%
418%
442%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS



AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0.26
0.24
0.33
0.28
-
-
-
-
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Dec2025

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
14.57%
-157.25%
-37.69%
-44.39%
-27.93%
-168.71%
-34%
-20.61%
QtrlyTrend
-6
Latest Qtr: Dec2025
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on Feb 13,2026, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Feb 13,2026, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on Feb 13,2026, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 12.40 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 0.79
Fair Value [Median EV / Sales Model] : Rs. 12.99
Fair Value [Median Price / Sales Model] : Rs. 12.40
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 12.40

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Feb 13,2026, AAREY DRUGS & PHARMACEUTICALS is trading at a Premium of 442% based on the estimates of Median Intrinsic Value!